SEI Investments
GTHX

SEI Investments’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

SEI Investments’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-44,600
Closed -$515K – 2550
2020
Q3 		$515K Buy
+44,600
New +$736K ﹤0.01% 1881
2019
Q4 		– Sell
-12,311
Closed -$280K – 2458
2019
Q3 		$280K Buy
+12,311
New +$388K ﹤0.01% 2143

Other funds holding GTHX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SEI Investments's GTHX Position: Q4 2020 in Review

SEI Investments sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2020, closing a stake of 44,600 shares — an estimated $515K sold.

SEI Investments first reported a position in GTHX in Q3 2019 and held it in 2 quarters. The position peaked at $515K in Q3 2020. 125 funds tracked by Wall St. Rank hold GTHX as of Q4 2020.

  • SEI Investments reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • SEI Investments sold 44,600 G1 Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $515K.
  • SEI Investments first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • SEI Investments's G1 Therapeutics, Inc. Common Stock position peaked at $515K in Q3 2020.
  • 125 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.